ABOS - Balance Sheet - Acumen Pharmaceuticals, Inc.

Current Liabilities	27.6 M
Accounts Payable	5.65 M
Short-Term Debt	133 K
Other Current Liabilities	21.8 M
Non-Current Liabilities	29.6 M
Long-Term Debt	28.6 M
Other Non-Current Liabilities	970 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	35.6	66.9	130.1	122.2	43.8	6.6
Short Term Investments	135.9	176.6	47.5	72.1	0	0
Receivables	0	0.2	0	0	0.1	30 K
Inventory	0	0	0	0	0	0
Other Current Assets	6.4	2.9	2.7	4.4	0.5	1.1
Total Current Assets	178.3	246.6	180.3	198.7	44.4	7.2
PP&E	0.3	0.5	0.3	36 K	0	0
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	60.0	62.6	15.8	31.6	0	0
Other Long Term Assets	0.4	0.5	0.2	14 K	0	0.1
Other Assets	0	0	0	0	0	0
Total Assets	239.0	310.1	196.6	230.3	44.4	7.3
LIABILITIES
Accounts Payable	5.6	1.4	1.6	1.1	0.5	0.2
Short Term Debt	0.1	1.7	0.2	0	0	0
Other Current Liabilities	21.8	9.9	6.0	4.1	5.8	1.1
Total Current Liabilities	27.6	13.0	7.8	5.1	6.4	1.3
Long Term Debt	28.6	27.6	0	0	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	1.0	2.6	0	0	56.7	17.4
Total Liabilities	57.2	43.2	7.8	5.1	63.0	18.7
EQUITY
Common Stock	6 K	6 K	4 K	4 K	0	0
Retained Earnings	(325.1)	(222.8)	(170.4)	(127.6)	(27.0)	(19.6)
Other Accumulative Comprehensive Income/Loss	48 K	0.3	(0.8)	(0.2)	0	0
Total Equity	181.8	267.0	188.8	225.2	(18.6)	(11.4)
Total Liabilities and Equity	239.0	310.1	196.6	230.3	44.4	7.3
SHARES OUTSTANDING
Common Shares Outstanding	60.0	48.5	40.6	40.5	40.2	40.2

Free